Persistent complete donor chimerism is an important clinical indicator for remissions of he-matological malignancies after HLA-matched allogeneic stem cell transplantation (SCT). However, the mechanisms mediating the persistence of complete donor chimerism are poorly understood. The frequent coincidence of complete donor chimerism with graft-ver-sus-leukemia effects and graft-versus-host disease suggests that immune responses against minor histocompatibility antigens (mHags) are playing an important role in sup-pressing the host hematopoiesis after allogeneic SCT. Here, we investigated a possible re-lationship between donor immune responses against the hematopoiesis-restricted mHag HA-1 and the long-term kinetics of host hematopoietic chime...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
INTRODUCTION: Minor histocompatibility antigen HA-1 (MiHAg-HA-1) disparity between a patient and his...
BACKGROUND: Transplantation of hematopoietic stem cells from partially matched family donors is a pr...
<div><p>Persistent complete donor chimerism is an important clinical indicator for remissions of hem...
Persistent complete donor chimerism is an important clinical indicator for remissions of hematologic...
Allogeneic hematopoietic stem cell transplantation (HSCT) is one of curative treatment options for p...
Allogeneic stem cell transplantation (alloSCT) can be a curative treatment for h...
INTRODUCTION: We previously reported the initial results of a phase II multicenter transplant trial ...
Contains fulltext : 30117_charoflea.pdf (publisher's version ) (Open Access)This t...
Background: The impact of HLA and KIR ligand mismatching on the outcome of hemato-poietic stem cell ...
International audienceBACKGROUND: After HLA-identical hematopoietic stem cell transplantation, minor...
International audienceThe effect of minor H antigen mismatching on the occurrence of graft-versus-ho...
Contains fulltext : 19390.pdf (publisher's version ) (Open Access)Allogeneic hemat...
BACKGROUND: After allogeneic hematopoietic stem-cell transplantation (HSCT), donor-derived T cells m...
16th IHIW: international histocompatibility working group in hematopoietic cell transplantation PETE...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
INTRODUCTION: Minor histocompatibility antigen HA-1 (MiHAg-HA-1) disparity between a patient and his...
BACKGROUND: Transplantation of hematopoietic stem cells from partially matched family donors is a pr...
<div><p>Persistent complete donor chimerism is an important clinical indicator for remissions of hem...
Persistent complete donor chimerism is an important clinical indicator for remissions of hematologic...
Allogeneic hematopoietic stem cell transplantation (HSCT) is one of curative treatment options for p...
Allogeneic stem cell transplantation (alloSCT) can be a curative treatment for h...
INTRODUCTION: We previously reported the initial results of a phase II multicenter transplant trial ...
Contains fulltext : 30117_charoflea.pdf (publisher's version ) (Open Access)This t...
Background: The impact of HLA and KIR ligand mismatching on the outcome of hemato-poietic stem cell ...
International audienceBACKGROUND: After HLA-identical hematopoietic stem cell transplantation, minor...
International audienceThe effect of minor H antigen mismatching on the occurrence of graft-versus-ho...
Contains fulltext : 19390.pdf (publisher's version ) (Open Access)Allogeneic hemat...
BACKGROUND: After allogeneic hematopoietic stem-cell transplantation (HSCT), donor-derived T cells m...
16th IHIW: international histocompatibility working group in hematopoietic cell transplantation PETE...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
INTRODUCTION: Minor histocompatibility antigen HA-1 (MiHAg-HA-1) disparity between a patient and his...
BACKGROUND: Transplantation of hematopoietic stem cells from partially matched family donors is a pr...